首页 > 市场调查报告书 > 製药

非专利药糖尿病生技仿製药

市场调查报告书

商品编码

1767702

按年龄层、强度、剂型、最终用户、分销管道和地区分類的 Lantus 市场

Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography

出版日期: 2025年06月27日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

兰塔斯市场规模预计在 2025 年达到 21.1 亿美元，预计到 2032 年将达到 31.4 亿美元，2025 年至 2032 年的复合年增长率为 5.84%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	21.1亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	5.84%	2032年价值预测	31.4亿美元

全球 Lantus 市场是糖尿病药物的关键领域，专注于长效胰岛素製剂，旨在为第 1 型和第 2 型糖尿病患者提供持续的血糖控制。 Lantus（Insulin Glargine）是一种合成的长效基础胰岛素类似物製剂，可模拟人体的自然胰岛素分泌模式，每日一次给药即可提供 24 小时血糖控制。市面上有各种剂型，包括管瓶和预填充笔，可满足不同患者的偏好和全球医疗保健提供系统的需求。这个市场的重要性归因于全球糖尿病盛行率的不断上升，糖尿病影响着全球超过 5.37 亿成年人，预计未来几十年将大幅增加。胰岛素输送系统的技术进步，加上病患遵从性和治疗效果的改善，使 Lantus 成为糖尿病管理通讯协定的基石疗法。市场动态受到专利到期、生物相似药竞争、法规结构、医疗保健基础设施发展以及强调个人化糖尿病治疗方法以实现最佳患者疗效的新兴市场治疗指南等因素的影响。

市场动态

全球Lantus市场受到多个关键驱动因素的支撑，这些因素持续塑造其成长轨迹。关键驱动因素包括全球糖尿病疫情的恶化，尤其是第2型糖尿病，其主要原因是久坐不动的生活方式、饮食习惯的改变以及已开发经济体和新兴经济体肥胖率的上升。 Lantus卓越的药物动力学特性促进了医生的偏好和患者的接受，因为与传统胰岛素製剂相比，它能够提供更低的胰岛素峰值作用和更少的低血糖发作。同时，包括智慧胰岛素笔和连网型设备在内的给药机制的持续创新提高了治疗依从性和监测能力。然而，该市场面临专利悬崖的重大阻碍因素，为生物相似药的竞争打开了大门，并显着影响了定价策略和市场占有率动态。同时，新製剂和给药系统的严格监管核准流程也成为市场进入和扩张的障碍。此外，控制医疗成本的压力（尤其是在新兴市场），以及复杂的报销制度和不同的保险覆盖政策，限制了市场准入和市场发展潜力。儘管面临这些挑战，糖尿病盛行率仍在快速上升，但在亚太、拉丁美洲和非洲等新兴市场，治疗渗透率仍然较低，这带来了尚未开发的市场潜力。持续血糖监测系统和人工智慧糖尿病管理平台等数位健康技术的整合，为改善患者预后和实现市场差异化提供了机会。同时，人们对糖尿病併发症和血糖控制重要性的认识不断提高，推动了已开发经济体和新兴经济体医疗保健体系对来得时等高端胰岛素治疗产品的需求。

本研究的主要特点

本报告对全球 Lantus 市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（以十亿美元为单位）和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、性能和策略等参数概述了全球 Lantus 市场的主要企业。
主要企业包括赛诺菲。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球 Lantus 市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
透过用于分析全球兰塔斯市场的各种策略矩阵，相关人员将发现决策更加容易。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2.11 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.84%	2032 Value Projection:	USD 3.14 Bn

The global Lantus market represents a critical segment within the diabetes therapeutics landscape, focusing on long-acting insulin formulations designed to provide sustained glycemic control for patients with Type 1 and Type 2 diabetes mellitus. Lantus (insulin glargine) is a synthetic, long-acting basal insulin analog that mimics the body's natural insulin production pattern, offering 24-hour glucose control with once-daily dosing. This market encompasses various formulations including vials, pre-filled pens, catering to diverse patient preferences and healthcare delivery systems globally. The market's significance stems from the growing prevalence of diabetes worldwide, affecting over 537 million adults globally, with projections indicating substantial increases in the coming decades. Technological advancements in insulin delivery systems, coupled with improved patient compliance and outcomes, have positioned Lantus as a cornerstone therapy in diabetes management protocols. The market dynamics are influenced by factors including patent expirations, biosimilar competition, regulatory frameworks, healthcare infrastructure development, and evolving treatment guidelines that emphasize personalized diabetes care approaches for optimal patient outcomes.

Market Dynamics

The global Lantus market is propelled by several key drivers that continue to shape its growth trajectory, with the primary catalyst being the escalating global diabetes epidemic, particularly Type 2 diabetes, driven by sedentary lifestyles, dietary changes, and increasing obesity rates across developed and emerging economies. The superior pharmacokinetic profile of Lantus, offering peak less insulin action and reduced hypoglycemic episodes compared to conventional insulin formulations, drives physician preference and patient adoption, while continuous innovation in delivery mechanisms including smart insulin pens and connected devices enhances treatment adherence and monitoring capabilities. However, the market faces significant restraints including patent cliff challenges that have opened doors for biosimilar competition, substantially impacting pricing strategies and market share dynamics, while stringent regulatory approval processes for new formulations and delivery systems create barriers to market entry and expansion. Additionally, healthcare cost containment pressures, particularly in developed markets, along with complex reimbursement landscapes and varying insurance coverage policies, limit market accessibility and growth potential. Despite these challenges, substantial opportunities emerge from expanding healthcare infrastructure in emerging markets across Asia-Pacific, Latin America, and Africa, where diabetes prevalence is rising rapidly but treatment penetration remains low, creating untapped market potential. The integration of digital health technologies, including continuous glucose monitoring systems and artificial intelligence-driven diabetes management platforms, presents opportunities for enhanced patient outcomes and market differentiation, while growing awareness about diabetes complications and the importance of glycemic control drives demand for premium insulin therapies like Lantus in both developed and developing healthcare systems.

Key Features of the Study

This report provides in-depth analysis of the global Lantus market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Lantus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key company covered as a part of this study include Sanofi.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Lantus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Lantus market.

Market Segmentation

Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
Strength Insights (Revenue, USD Bn, 2020 - 2032)
- 10 mL
- 3 mL
Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
- Multi-dose Vial
- Single Patient use Prefilled pen
End User Insights (Revenue, USD, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Long-Term Care Facilities
- Others (Home Care Settings, etc.)
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Sanofi

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Lantus Market, By Age Group
- Global Lantus Market, By Strength
- Global Lantus Market, By Dosage Form
- Global Lantus Market, By End User
- Global Lantus Market, By Distribution Channel
- Global Lantus Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends
Epidemiology
Treatment Option Analysis
Price Differentiation Analysis (Lantus and Biosimilars)
Reimbursement Scenario
Adherence and Switch Rate Analysis in U.S.
Disease Awareness Programs

4. Global Lantus Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Lantus Market, By Strength, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
10 mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
3 mL
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Lantus Market, By Dosage Form, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Multi-dose Vial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Single Patient use Prefilled pen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lantus Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Long-Term Care Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Home Care Settings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lantus Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lantus Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

按年龄层、强度、剂型、最终用户、分销管道和地区分類的 Lantus 市场

Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography

市场动态

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 2020 年至 2032 年按年龄分類的全球 Lantus 市场

5. 全球 Lantus 市场（依实力划分），2020 年至 2032 年

6. 2020 年至 2032 年全球 Lantus 市场（依剂型划分）

7. 全球 Lantus 市场（以最终用户划分），2020 年至 2032 年

8. 全球 Lantus 市场（依分销管道划分），2020 年至 2032 年

第九章。 2020 年至 2032 年按地区分類的全球 Lantus 市场

第十章竞争格局

第 11 章分析师建议

第十二章参考文献与调查方法